LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives $94.57 Average PT from Analysts
LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) has earned an average rating of “Moderate Buy” from the nine research firms that are currently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has given a strong buy recommendation […]
LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) has earned an average rating of “Moderate Buy” from the nine research firms that are currently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has given a strong buy recommendation […]
